Word

ENOVANT TECHNOLOGIES

Status

Dead

Status Code

711

Status Date

Wednesday, September 8, 2021

Serial Number

88111827

Registration Number

5999691

Registration Date

Tuesday, March 3, 2020

Mark Type

4000

Filing Date

Tuesday, September 11, 2018

Published for Opposition

Tuesday, December 17, 2019

Cancellation Date

Wednesday, September 8, 2021

Trademark Owner History

Roivant Sciences GmbH - Original Registrant

Classifications

9 Computer software using artificial intelligence for providing, analyzing and generating reports; computer software for providing, analyzing and generating reports; computer software for data processing; computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images, information; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceutical and biomedical research and development, clinical and post-market trials, and the provision of medical and healthcare services; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and news information of general interest; computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information

35 Business consulting services; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business advisory services, consultancy and information; market intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; professional business analysis and consultancy and statistical analysis in the fields of healthcare, biomedicine, pharmaceuticals, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and research evaluating epidemiological outcomes; providing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare from an on-line database; providing commercial and business contact information within the scientific research and medical communities to achieve advances in the field of healthcare; business networking services within the scientific research and medical communities to achieve advances in the field of healthcare; compilation of data, analysis of business data and professional business analysis in the field of pharmaceutical and biomedical research and development, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; compilation of data, analysis of business data and professional business analysis for medical and healthcare for business purposes; providing reimbursement benchmarking information and other market intelligence to healthcare organizations; collecting and professional business analysis of claims data from healthcare organizations for business purposes; business services provided to the healthcare industry, namely, the collection, reporting, and professional business analysis of healthcare data for business purposes

36 Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data for financial purposes; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to securities and other financial instruments; financial research related to financial instruments

42 Scientific and technological services, namely, scientific research and analysis, and diagnostic services in the field of pharmaceuticals and biomedicine; industrial analysis and research services in the field of pharmaceuticals and biomedicine; design and development of computer hardware and software; data processing analysis services; analysis of scientific data; pharmaceutical and biomedical research services; conducting clinical trials and post-market trials; epidemiological research services, pharmacoepidemiological research services; providing temporary use of non-downloadable software applications accessible via a web site regarding analytics of data for use in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, and pharmacoepidemiological research; providing on-line information in the fields of pharmaceutical research, biomedical research, epidemiological research, pharmacoepidemiological research, and clinical trial and post-market trial data via a computer database or the Internet; providing scientific research information in the fields of healthcare, biomedicine, pharmaceuticals, and clinical and post-market clinical trials; providing temporary use of non-downloadable software applications accessible via a web site for data analytics and financial analytics for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; compiling data for research and analysis for medical science purposes in the field of healthcare, pharmaceuticals, biomedicine, clinical trials and post-market trials

"TECHNOLOGIES"

Trademark Events

Sep 8, 2021

Cancelled Section 7-Total

Sep 8, 2021

Cancellation Terminated No. 999999

Sep 8, 2021

Cancellation Denied No. 999999

Jun 15, 2021

Cancellation Instituted No. 999999

Mar 3, 2020

Registered-Principal Register

Dec 17, 2019

Official Gazette Publication Confirmation E-Mailed

Dec 17, 2019

Published For Opposition

Nov 27, 2019

Notification Of Notice Of Publication E-Mailed

Nov 13, 2019

Approved For Pub - Principal Register

Oct 29, 2019

Examiner's Amendment Entered

Oct 29, 2019

Notification Of Examiners Amendment E-Mailed

Oct 29, 2019

Examiners Amendment E-Mailed

Oct 29, 2019

Examiners Amendment -Written

May 3, 2019

Notification Of Non-Final Action E-Mailed

May 3, 2019

Non-Final Action E-Mailed

May 3, 2019

Non-Final Action Written

Apr 16, 2019

Teas/Email Correspondence Entered

Apr 15, 2019

Correspondence Received In Law Office

Apr 15, 2019

Teas Response To Office Action Received

Oct 16, 2018

Notification Of Non-Final Action E-Mailed

Oct 16, 2018

Non-Final Action E-Mailed

Oct 16, 2018

Non-Final Action Written

Oct 10, 2018

Assigned To Examiner

Oct 2, 2018

Preliminary/Voluntary Amendment - Entered

Sep 30, 2018

Assigned To Lie

Sep 20, 2018

Teas Voluntary Amendment Received

Sep 18, 2018

New Application Office Supplied Data Entered In Tram

Sep 14, 2018

New Application Entered In Tram